134 related articles for article (PubMed ID: 30819811)
1. Centrally located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumour centrality with dedicated imaging software.
Casal RF; Sepesi B; Sagar AS; Tschirren J; Chen M; Li L; Sunny J; Williams J; Grosu HB; Eapen GA; Jimenez CA; Ost DE
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819811
[TBL] [Abstract][Full Text] [Related]
2. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
Decaluwé H; Moons J; Fieuws S; De Wever W; Deroose C; Stanzi A; Depypere L; Nackaerts K; Coolen J; Lambrecht M; Verbeken E; De Ruysscher D; Vansteenkiste J; Van Raemdonck D; De Leyn P; Dooms C;
Eur J Cardiothorac Surg; 2018 Jul; 54(1):134-140. PubMed ID: 29447330
[TBL] [Abstract][Full Text] [Related]
3. Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Shin SH; Jeong DY; Lee KS; Cho JH; Choi YS; Lee K; Um SW; Kim H; Jeong BH
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635291
[TBL] [Abstract][Full Text] [Related]
4. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
5. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
6. Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
Decaluwé H; Stanzi A; Dooms C; Fieuws S; Coosemans W; Depypere L; Deroose CM; Dewever W; Nafteux P; Peeters S; Van Veer H; Verbeken E; Van Raemdonck D; Moons J; De Leyn P;
Eur J Cardiothorac Surg; 2016 Jul; 50(1):110-7. PubMed ID: 26819286
[TBL] [Abstract][Full Text] [Related]
7. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
8. Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer†.
Decaluwé H; Petersen RH; Brunelli A; Pompili C; Seguin-Givelet A; Gust L; Aigner C; Falcoz PE; Rinieri P; Augustin F; Sokolow Y; Verhagen A; Depypere L; Papagiannopoulos K; Gossot D; D'Journo XB; Guerrera F; Baste JM; Schmid T; Stanzi A; Van Raemdonck D; Bardet J; Thomas PA; Massard G; Fieuws S; Moons J; Dooms C; De Leyn P; Hansen HJ;
Eur J Cardiothorac Surg; 2018 Feb; 53(2):359-365. PubMed ID: 29029062
[TBL] [Abstract][Full Text] [Related]
9. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
10. Definitions of Central Tumors in Radiologically Node-Negative, Early-Stage Lung Cancer for Preoperative Mediastinal Lymph Node Staging: A Dual-Institution, Multireader Study.
Kim H; Choi H; Lee KH; Cho S; Park CM; Kim YT; Goo JM
Chest; 2022 May; 161(5):1393-1406. PubMed ID: 34785237
[TBL] [Abstract][Full Text] [Related]
11. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Gómez-Caro A; Garcia S; Reguart N; Arguis P; Sanchez M; Gimferrer JM; Marrades R; Lomeña F
Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
[TBL] [Abstract][Full Text] [Related]
13. Geometrical Measurement of Central Tumor Location in cT1N0M0 NSCLC Predicts N1 but Not N2 Upstaging.
Sanz-Santos J; Martínez-Palau M; Jaen À; Rami-Porta R; Barreiro B; Call S; Obiols C; González JM; De Marcos JÁ; Ysamat M; Canales L; Serra M; Belda J
Ann Thorac Surg; 2021 Apr; 111(4):1190-1197. PubMed ID: 32853568
[TBL] [Abstract][Full Text] [Related]
14. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
15. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.
Barnett S; Baste JM; Murugappan K; Tog C; Berlangieri S; Scott A; Seevanayagam S; Knight S
Eur J Cardiothorac Surg; 2011 Jan; 39(1):96-101. PubMed ID: 20580245
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
[TBL] [Abstract][Full Text] [Related]
18. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
19. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
[TBL] [Abstract][Full Text] [Related]
20. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
